SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-18-004567
Filing Date
2018-04-02
Accepted
2018-04-02 17:31:47
Documents
62
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1776016
2 ex23-1.htm EX-23.1 3253
3 ex23-2.htm EX-23.2 3440
4 ex31-2.htm EX-31.2 22035
5 ex32-1.htm EX-32.1 11738
  Complete submission text file 0001493152-18-004567.txt   5085874

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ptix-20171231.xml EX-101.INS 610677
7 XBRL SCHEMA FILE ptix-20171231.xsd EX-101.SCH 47383
8 XBRL CALCULATION FILE ptix-20171231_cal.xml EX-101.CAL 51823
9 XBRL DEFINITION FILE ptix-20171231_def.xml EX-101.DEF 229324
10 XBRL LABEL FILE ptix-20171231_lab.xml EX-101.LAB 361891
11 XBRL PRESENTATION FILE ptix-20171231_pre.xml EX-101.PRE 309591
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51353 | Film No.: 18730494
SIC: 7389 Services-Business Services, NEC